B

Bangkok Lab and Cosmetic PCL
SET:BLC

Watchlist Manager
Bangkok Lab and Cosmetic PCL
SET:BLC
Watchlist
Price: 5.35 THB Market Closed
Market Cap: 3.2B THB
Have any thoughts about
Bangkok Lab and Cosmetic PCL?
Write Note

Bangkok Lab and Cosmetic PCL
Income from Continuing Operations

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Bangkok Lab and Cosmetic PCL
Income from Continuing Operations Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Income from Continuing Operations CAGR 3Y CAGR 5Y CAGR 10Y
B
Bangkok Lab and Cosmetic PCL
SET:BLC
Income from Continuing Operations
฿150.8m
CAGR 3-Years
122%
CAGR 5-Years
53%
CAGR 10-Years
N/A
M
Mega Lifesciences PCL
SET:MEGA
Income from Continuing Operations
฿1.8B
CAGR 3-Years
0%
CAGR 5-Years
10%
CAGR 10-Years
15%
No Stocks Found

Bangkok Lab and Cosmetic PCL
Glance View

Market Cap
3.2B THB
Industry
Pharmaceuticals

Bangkok Lab & Cosmetic PCL engaes in the provision of pharmaceuticals and health products. The company is headquartered in Bangkok, Bangkok Metropolis. The company went IPO on 2023-06-21. The firm is engaged in the production of medicines and health products by selecting raw materials. The firm has produced more than 100 products. Its products include ZENZERA 200 SUSPENSION, ZENZERA, SYNOVAR UC40, RADIARA, PROCEMINE, FANGO-B, EMBLICOF COUGH MIXTURE, CLINIGEL STERILE, RAQUA FIBROTA, RAQUA COLLAGEN, SYNOVAR UC, SYNOVAR POWDER, NACOXIB, LUTI-BERRY MIXED, ZIGA GEL (orange), ZERTINE SYRUP, VIZO Cream, SPORAXYL CREAM, NORAPHEN, MURHINOL-250 SYRUP, NORFLOXYL 400, NOCID, MURHINOL-250 SYRUP, MUCOBROX, GYNOSTEN CREAM, and GYNOSTEN 500, AROTIKA COOL GEL, ALLERAX-FC, AROTIKA RUB LOTION (SPRAY), Calza c Dietary Supplement, Calza PLUS POWDER Dietary, and Calza-750 TAB FC, among others. Its products are distributed through Bangkok Drug Co., Ltd., Beereach (Thailand) Co., Ltd., Pharmaline Company Limited, Pharma Alliance Company Ltd., and Bangkok Medica Co., Ltd.

BLC Intrinsic Value
3.76 THB
Overvaluation 30%
Intrinsic Value
Price
B

See Also

What is Bangkok Lab and Cosmetic PCL's Income from Continuing Operations?
Income from Continuing Operations
150.8m THB

Based on the financial report for Dec 31, 2023, Bangkok Lab and Cosmetic PCL's Income from Continuing Operations amounts to 150.8m THB.

What is Bangkok Lab and Cosmetic PCL's Income from Continuing Operations growth rate?
Income from Continuing Operations CAGR 5Y
53%

Over the last year, the Income from Continuing Operations growth was 16%. The average annual Income from Continuing Operations growth rates for Bangkok Lab and Cosmetic PCL have been 122% over the past three years , 53% over the past five years .

Back to Top